Powered by Anthropic's Claude, Sentira Single Cell enables researchers to analyze Chromium data using natural language, accelerating the path from scientific questions to experimental conclusions PLEASANTON, Calif., Nov. 2, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life...
The U.S. Food and Drug Administration today issued final guidance for manufacturers of cellular and gene therapy (CGT) products to implement a comprehensive, science- and risk-based plan for making sure their products meet potency standards.
New radio expands Askey's portfolio for dedicated enterprise wireless deployments FREMONT, Calif., Nov. 2, 2026 /PRNewswire/ -- Askey today announced the SCU5050, a new 4×4 MIMO small cell radio for private 5G networks. The SCU5050 gives enterprises, system integrators, and network...
Background and Aims: APOBEC-associated mutagenesis is prominent in esophageal squamous cell carcinoma (ESCC), but genomic features associated with its intertumoral variability remain incompletely characterized. We investigated genomic correlates of APOBEC-associated mutagenesis while accounting for…
[Addis Standard] Addis Abeba -- US Customs and Border Protection (CBP) has released shipments of solar cells manufactured at a Japanese company's facility in Ethiopia following a review of its supply chain documentation, SolarQuarter reported.
Gene therapies utilizing hematopoietic stem and progenitor cells (HSPCs) have curative potential across hematologic diseases, but manual manufacturing workflows are costly and difficult to scale, limiting patient access. Here, we demonstrated automation of an HSPC gene knock-in protocol on a…
Despite frequent pathway activation, targeted molecular therapy remains limited in head and neck squamous cell carcinoma (HNSCC), highlighting the need to distinguish activation from dependence. Dependency is functional, context-specific, and coupled; mutations or expression alone cannot establish…
Epigenetic memory, reinforced by redundant heterochromatic networks, is a major barrier to somatic cell reprogramming. In cattle, single-agent chromatin-modifying treatments show inconsistent efficacy, likely due to compensatory crosstalk among repressive marks. Here, we evaluated a multi-target…
In this free webinar, learn how cell and gene therapy (CGT) sponsors can use FDA meetings to guide development from early planning through marketing application readiness. The featured speakers will discuss INTERACT, pre-IND, Type D and pre-BLA meetings, including when to use them and how...
Pancreatic ductal adenocarcinoma (PDAC) is characterized by early invasion, metastasis, and therapeutic resistance that contribute substantially to its poor clinical outcome. Keratin 17 (K17) is a recognized marker of the aggressive basal-like subtype of PDAC and an independent predictor of adverse…
